Day One Biopharmaceuticals Inc (DAWN)
Operating Income Growth
41.20%
TTM · Period ending:
DAWN Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported41.20%period ending
Latest reported41.20%period ending
DAWN TTM Operating Income YoY % (-427.76% → 41.20%)
Year-over-year change
High-resolution chart · PNG
DAWN operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| 41.2022% | |
| 21.6741% | |
| 61.8031% | |
| 15.599% | |
| -5.4381% | |
| -11.7095% | |
| -64.7577% | |
| -37.5479% | |
| -40.2664% | |
| -50.0622% | |
| -68.0034% | |
| -95.5096% | |
| -101.9618% | |
| -121.65% | |
| -156.3255% | |
| -200.3665% | |
| -427.7588% |